CDEK
← Mechanisms of action

TPBG

SINGLE PROTEINHomo sapiens
Preferred name: Trophoblast glycoprotein ChEMBL ↗

Linked proteins

Drugs acting on this target (19)

Active Pharmaceutical Ingredient Mechanism Type ▲ Approval Status API Type Mechanism of Action
pf-06263507Binding agentexperimentalmAbTrophoblast glycoprotein binding agent
durvalumab (imfinzi)Cross-linking agentapprovedmAbTPBG cross-linking agent
bb-mpi-03Immunity, activeexperimentalVaccineTPBG immunity, active
chadox1-mva 5t4Immunity, activeexperimentalVaccineTPBG immunity, active
modified vaccinia ankara-5t4 vaccineImmunity, activeexperimentalVaccineTPBG immunity, active
anti-5t4 car-rank cellsImmunity, passiveexperimentalCell therapyTPBG immunity, passive
ibr854Immunity, passiveexperimentalCell therapyimmunity, passive - 5T4
alg.apv-527InhibitorexperimentalmAbTPBG inhibitor
asn004InhibitorexperimentalmAbTPBG inhibitor
cba-1535InhibitorexperimentalmAbTPBG inhibitor
ftl008.16InhibitorexperimentalmAbTPBG inhibitor
gen1044InhibitorexperimentalmAbTPBG inhibitor
jk06InhibitorexperimentalmAbTPBG inhibitor
naptumomab estafenatoxInhibitorexperimentalmAbTPBG inhibitor
pf-06263507InhibitorexperimentalmAbTPBG inhibitor
syd1875InhibitorexperimentalmAbTPBG inhibitor
tub-030InhibitorexperimentalmAbTPBG inhibitor
xb010InhibitorexperimentalmAbTPBG inhibitor
naptumomab estafenatoxOtherexperimentalmAbTPBG other